Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Depot somatostatin analogs--a new first line therapy for acromegaly.

× No keyword cloud information.

5 in total

1. Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly.

Authors: R Cozzi; M Barausse; M Sberna; A Lodrini; A Franzini; G Lasio; R Attanasio
Journal: Pituitary Date: 2000-12 Impact factor: 4.107

Review 2. Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly.

Authors: J C Gillis; S Noble; K L Goa
Journal: Drugs Date: 1997-04 Impact factor: 9.546

3. GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide.

Authors: R Attanasio; M Barausse; R Cozzi
Journal: J Endocrinol Invest Date: 2001-04 Impact factor: 4.256

Review 4. New medical treatment for acromegaly.

Authors: A J van der Lely; W W de Herder; S W Lamberts
Journal: Pituitary Date: 1999-06 Impact factor: 4.107

5. Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative study.

Authors: S Grottoli; R Celleno; V Gasco; R Pivonello; D Caramella; A Barreca; F Ragazzoni; F Pigliaru; D Alberti; R Ferrara; G Angeletti
Journal: J Endocrinol Invest Date: 2005-12 Impact factor: 4.256

5 in total